Tyra Biosciences (TYRA) Current Assets (2020 - 2026)

Tyra Biosciences has reported Current Assets for 7 years, with the latest figure at $394.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 21.58% year-over-year to $394.6 million; the trailing twelve-month figure through Mar 2026 stood at $394.6 million (up 21.58% YoY), and the FY2025 full-year result was $265.4 million, down 23.6% from the prior year.
• Current Assets for Q1 2026 stood at $394.6 million, up from $265.4 million in the prior quarter.
• The five-year high for Current Assets was $394.6 million in Q1 2026, with the low at $211.7 million in Q4 2023.
• Historically, Current Assets has averaged $298.3 million across 5 years, with a median of $281.2 million in 2025.
• Annual changes were most pronounced in 2024 — Current Assets jumped 64.15% — and 2025, when it dropped 23.6%.
• Tyra Biosciences' Current Assets stood at $257.3 million in 2022, then fell by 17.73% to $211.7 million in 2023, then jumped by 64.15% to $347.5 million in 2024, then slipped by 23.6% to $265.4 million in 2025, then soared by 48.66% to $394.6 million in 2026.
• The last three Current Assets figures came in at $394.6 million (Q1 2026), $265.4 million (Q4 2025), and $281.2 million (Q3 2025), per Business Quant data.